Environmental toxicology: Sensitive periods of development and neurodevelopmental disorders

NeuroToxicology

Volumn 58, Issue , 2017, Pages 23-41

  Heyer, Djai B ^a   Meredith, Rhiannon M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

ADHD; Autism; Neurodevelopmental disorders; Prenatal; Schizophrenia; Toxicant

Indexed keywords

ARSENIC; CHLORPYRIFOS; LEAD; METHYLMERCURY; MISOPROSTOL; ORGANOCHLORINE DERIVATIVE; ORGANOPHOSPHATE; PESTICIDE; POLYCHLORINATED BIPHENYL; SEROTONIN UPTAKE INHIBITOR; THALIDOMIDE; THYROID HORMONE DERIVATIVE; VALPROIC ACID;

ATTENTION DEFICIT DISORDER; AUTISM; BRAIN DEVELOPMENT; BRAIN FUNCTION; CONGENITAL MALFORMATION; CYTOKINE PRODUCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL FACTOR; ENVIRONMENTAL TOXICOLOGY; HUMAN; IMMUNOPATHOLOGY; IMPULSIVENESS; INFECTION; IONIZING RADIATION; MALNUTRITION; MENTAL DISEASE; NERVE CELL EXCITABILITY; NEUROTOXICITY; NEUROTRANSMISSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POLLUTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TOXICOLOGY; ANIMAL; CHEMICALLY INDUCED; ECOTOXICOLOGY; TOXICITY AND INTOXICATION;

ANIMALS; ECOTOXICOLOGY; ENVIRONMENTAL POLLUTION; HUMANS; NEURODEVELOPMENTAL DISORDERS; NEUROTOXICITY SYNDROMES;

EID: 84995554218     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2016.10.017     Document Type: Review

References (196)

1. Abdel Rasoul, G.M., Abou Salem, M.E., Mechael, A. a., Hendy, O.M., Rohlman, D.S., Ismail, A.a., Effects of occupational pesticide exposure on children applying pesticides. Neurotoxicology 29 (2008), 833-838, 10.1016/j.neuro.2008.06.009.
2. Adams, J., Barone, S., LaMantia, A., Philen, R., Rice, D.C., Spear, L., Susser, E.S., Workshop to identify critical windows of exposure for children's health: neurobehavioral work group summary. Environ. Health Perspect. 108 (2000), 535-544.
3. Agrawal, A.K., Tilson, H.A., Bondy, S.C., 3,4,3’,4’-Tetrachlorobiphenyl given to mice prenatally produces long-term decreases in striatal dopamine and receptor binding sites in the caudate nucleus. Toxicol. Lett. 7 (1981), 417-424, 10.1016/0378-4274(81)90087-4.
4. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (Dsm-5). 2013, American Psychiatric Association, Washington DC.
5. Andersen, S., Laurberg, P., Wu, C., Olsen, J., Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG 121 (2014), 1365-1374, 10.1111/1471-0528.12681.
6. Andersen, S.L., Olsen, J., Laurberg, P., Fetal programming by maternal thyroid disease. Clin. Endocrinol. (Oxf.) 0 (2015), 1-8, 10.1111/cen.12744.
7. Anderson, G.M., Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J. Am. Acad. Child Adolesc. Psychiatry 41 (2002), 1513-1516, 10.1097/00004583-200212000-00025.
8. Arndt, T.L., Stodgell, C.J., Rodier, P.M., The teratology of autism. Int. J. Dev. Neurosci. 23 (2005), 189-199, 10.1016/j.ijdevneu.2004.11.001.
9. Atladóttir, H.Ó., Thorsen, P., Østergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., Parner, E.T., Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 40 (2010), 1423-1430, 10.1007/s10803-010-1006-y.
10. Azzam, E.I., Jay-Gerin, J.P., Pain, D., Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 327 (2012), 48-60, 10.1016/j.canlet.2011.12.012.
11. Baharnoori, M., Brake, W.G., Srivastava, L.K., Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats. Schizophr. Res. 107 (2009), 99-109, 10.1016/j.schres.2008.10.003.
12. Bandim, J.M., Ventura, L.O., Miller, M.T., Almeida, H.C., Costa, A.E.S., Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq. Neuropsiquiatr. 61 (2003), 181-185 10.1590/S0004-282X2003000200004.
13. Bellinger, D., Leviton, A., Allred, E., Rabinowitz, M., Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ. Res. 66:1 (1994), 12-30, 10.1006/enrs.1994.1041.
14. Belloni, V., Dessì-Fulgheri, F., Zaccaroni, M., Di Consiglio, E., De Angelis, G., Testai, E., Santochirico, M., Alleva, E., Santucci, D., Early exposure to low doses of atrazine affects behavior in juvenile and adult CD1 mice. Toxicology 279 (2011), 19-26, 10.1016/j.tox.2010.07.002.
15. Bitanihirwe, B.K.Y., Woo, T.-U.W., Oxidative stress in schizophrenia: an integrated approach. Neurosci. Biobevioral Rev. 35 (2011), 878-893, 10.1016/j.neubiorev.2010.10.008.
16. Borrell, J., Vela, J.M., Arévalo-Martin, A., Molina-Holgado, E., Guaza, C., Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002), 204-215, 10.1016/S0893-133X(01)00360-8.
17. Bouchard, M.F., Bellinger, D.C., Wright, R.O., Weisskopf, M.G., Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics 125 (2010), e1270-e1277, 10.1542/peds.2009-3058 2009-3058.
18. Boucher, O., Jacobson, S.W., Plusquellec, P., Dewailly, É., Ayotte, P., Forget-Dubois, N., Jacobson, J.L., Muckle, G., Prenatal methylmercury, postnatal lead exposure, and evidence of attention deficit/hyperactivity disorder among Inuit children in Arctic Québec. Environ. Health Perspect. 120 (2012), 1456-1461, 10.1289/ehp.1204976.
19. Braun, J.M., Kahn, R.S., Froehlich, T., Auinger, P., Lanphear, B.P., Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ. Health Perspect. 114 (2006), 1904-1909, 10.1289/ehp.9478.
20. Braun, J.M., Froehlich, T.E., Daniels, J.L., Dietrich, K.N., Hornung, R., Auinger, P., Lanphear, B.P., Association of environmental toxicants and conduct disorder in U.S. children: NHANES 2001-2004. Environ. Health Perspect. 116 (2008), 956-962, 10.1289/ehp.11177.
21. Braun, J.M., Kalkbrenner, a. E., Calafat, a. M., Yolton, K., Ye, X., Dietrich, K.N., Lanphear, B.P., Impact of early-life bisphenol an exposure on behavior and executive function in children. Pediatrics 128 (2011), 873-882, 10.1542/peds 2011-1335.
22. Brennan, A.R., Arnsten, A.F.T., Neuronal mechanisms underlying attention deficit hyperactivity disorder. Ann. N.Y. Acad. Sci. 1129 (2008), 236-245, 10.1196/annals.1417.007.
23. Brown, A.S., Susser, E.S., In utero infection and adult schizophrenia. Ment. Retard. Dev. Disabil. Res. Rev. 8 (2002), 51-57, 10.1002/mrdd.10004.
24. Brown, A.S., Susser, E.S., Butler, P.D., Richardson Andrews, R., Kaufmann, C.A., Gorman, J.M., Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J. Nerv. Ment. Dis. 184:2 (1996), 71-85, 10.1097/00005053-199602000-00003.
25. Brown, A.S., Begg, M.D., Gravenstein, S., Schaefer, C.A., Wyatt, R.J., Bresnahan, M., Babulas, V.P., Susser, E.S., Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 61 (2004), 774-780, 10.1097/01.ogx.0000151642.60544.d2.
26. Brown, A.S., Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 32 (2006), 200-202, 10.1093/schbul/sbj052.
27. Brown, A.S., Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev. Neurobiol. 72 (2012), 1272-1276, 10.1002/dneu.22024.
28. Buka, S.L., Tsuang, M.T., Torrey, E.F., Klebanoff, M.A., Wagner, R.L., Yolken, R.H., Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav. Immunol. 15 (2001), 411-420, 10.1006/brbi.2001.0644.
29. Calderón, J., Navarro, M.E., Jimenez-Capdeville, M.E., Santos-Diaz, M.A., Golden, A., Rodriguez-Leyva, I., Borja-Aburto, V., Díaz-Barriga, F., Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ. Res. 85 (2001), 69-76, 10.1006/enrs.2000.4106.
30. Cao, Y., Chen, A., Jones, R., Radcliffe, J., Caldwell, K., Dietrich, K., Rogan, W.J., Does background postnatal methyl mercury exposure in toddlers affect cognition and behavior?. Neurotoxicology 31 (2010), 1-9, 10.1016/j.biotechadv.2011.08.021.
31. Castoldi, A.F., Coccini, T., Ceccatelli, S., Manzo, L., Neurotoxicity and molecular effects of methylmercury. Brain Res. Bull. 55 (2001), 197-203, 10.1016/S0361-9230(01)00458-0.
32. Ceylan, M.F., Sener, S., Bayraktar, A.C., Kavutcu, M., Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin. Neurosci. 66 (2012), 220-226, 10.1111/j.1440-1819.2012.02330.x.
33. Chen, S., Golemboski, K., Piepenbrink, M., Dietert, R., Developmental immunotoxicity of lead in the rat: influence of maternal diet. J. Toxicol. Environ. Health A 67 (2004), 495-511, 10.1080/15287390490276520.
34. Chen, A., Cai, B., Dietrich, K., Radcliffe, J., Rogan, W.J., Lead exposure, IQ, and behavior in urban 5-7 year olds: does lead affect behavior only by lowering IQ?. Pediatrics 119 (2007), 650-658, 10.1016/j.biotechadv.2011.08.021.
35. Chen, Y.-H., Chiou, H.-Y., Lin, H.-C., Lin, H.-L., Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch. Neurol. 66 (2009), 979-984, 10.1111/j.1535-7511.2009.01349.x.
36. Cheslack-Postava, K., Rantakokko, P., Hinkka-Yli-Salomaki, S., Surcel, H., McKeague, I., Kiviranta, H., Sourander, A., Brown, A.S., Maternal Serum Persistent Organic Pollutants in the Finnish prenatal study of autism: a pilot study. Neurotoxicol. Teratol. 38 (2013), 1-5, 10.1016/j.biotechadv.2011.08.021.
37. Chess, S., Autism in children with congenital rubella. J. Autism Child. Schizophr. 1 (1971), 33-47.
38. Chevrier, J., Gunier, R.B., Bradman, A., Holland, N.T., Calafat, A.M., Eskenazi, B., Harley, K.G., Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ. Health Perspect. 121 (2013), 138-144, 10.1289/ehp.1205092.
39. Chugani, D.C., Muzik, O., Behen, M., Rothermel, R., Janisse, J.J., Lee, J., Chugani, H.T., Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45 (1999), 287-295 10.1002/1531-8249(199903)45:3<287:AID-ANA3>3.0. CO;2-9.
40. Clancy, B., Finlay, B.L., Darlington, R.B., Anand, K.J.S., Extrapolating brain development from experimental species to humans. Neurotoxicology 28 (2007), 931-937, 10.1016/j.neuro.2007.01.014.
41. Costa, L.G., Aschner, M., Vitalone, A., Syversen, T., Soldin, O.P., Developmental neuropathology of environmental agents. Annu. Rev. Pharmacol. Toxicol. 44 (2004), 87-110, 10.1146/annurev.pharmtox.44.101802.121424.
42. Croen, L., Grether, J., Yoshida, C., Odouli, R., Hendrick, V., Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. Gen. Psychiatry 68 (2011), 1104-1112, 10.1001/archgenpsychiatry.2011.73.
43. De Cock, M., Maas, Y.G.H., Van De Bor, M., Does perinatal exposure to endocrine disruptors induce autism spectrum and attention deficit hyperactivity disorders?. Rev. Acta Paediatr. 101 (2012), 811-818, 10.1111/j.1651-2227.2012.02693.x.
44. Dietrich, K.N., Ris, M.D., Succop, P.A., Berger, O.G., Bornschein, R.L., Early exposure to lead and juvenile delinquency. Neurotoxicol. Teratol. 23 (2001), 511-518, 10.1016/s0892-0362(01)00184-2.
45. Dobbing, J., Sands, J., Comparative aspects of the brain growth spurt. Early Hum. Dev. 311 (1979), 79-83.
46. Dufour-Rainfray, D., Vourc'h, P., Le Guisquet, A.M., Garreau, L., Ternant, D., Bodard, S., Jaumain, E., Gulhan, Z., Belzung, C., Andres, C.R., Chalon, S., Guilloteau, D., Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett. 470:1 (2010), 55-59, 10.1016/j.neulet.2009.12.054.
47. Eaton, D.L., Daroff, R.B., Autrup, H., Bridges, J., Buffler, P., Costa, L.G., Coyle, J., McKhann, G., Mobley, W.C., Nadel, L., Neubert, D., Schulte-Hermann, R., Spencer, P.S., Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit. Rev. Toxicol. 38 (2008), 1-125, 10.1080/10408440802272158.
48. Elsworth, J.D., Jentsch, J.D., VandeVoort, C. a., Roth, R.H., Eugene Redmond, D., Leranth, C., Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates. Neurotoxicology 35 (2013), 113-120, 10.1016/j.neuro.2013.01.001.
49. Emiliani, F., Sedlak, T., Sawa, A., Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr. Opin. Psychiatry 27 (2014), 185-190, 10.1016/j.biotechadv.2011.08.021.
50. Eskenazi, B., Marks, A.R., Bradman, A., Harley, K., Barr, D., Johnson, C., Morga, N., Jewell, N.P., Organophosphate pesticide exposure and neurodevelopment in young mexican-American children. Environ. Health Perspect. 115 (2007), 792-798, 10.1097/00001648-200611001-00248.
51. Fatemi, S.H., Folsom, T.D., The neurodevelopmental hypothesis of Schizophrenia, revisited. Schizophr. Bull. 35 (2009), 528-548, 10.1093/schbul/sbn187.
52. Finkelstein, Y., Markowitz, M.E., Rosen, J.F., Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res. Rev. 27 (1998), 168-176, 10.1016/S0165-0173(98)00011-3.
53. Flatow, J., Buckley, P., Miller, B.J., Meta-analysis of oxidative stress in schizophrenia. Biol. Psychiatry 74 (2013), 400-409, 10.1016/j.biopsych.2013.03.018.
54. Flora, S.J., Pande, M., Kannan, G.M., Mehta, A., Lead induced oxidative stress and its recovery following co-administration of merlatonin or N-acetylcysteine during chelation with succimer in male rats. Cell. Mol. Biol. 50 (2004), OL543-OL551, 10.1170/67.
55. Floyd, R.A., Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26 (1999), 1346-1355.
56. Fonnum, F., Mariussen, E., Reistad, T., Molecular mechanisms involved in the toxic effects of polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs). J. Toxicol. Environ. Health 69 (2006), 21-35, 10.1080/15287390500259020.
57. Fortier, M.È., Joober, R., Luheshi, G.N., Boksa, P., Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J. Psychiatr. Res. 38 (2004), 335-345, 10.1016/j.jpsychires.2003.10.001.
58. Froehlich, T.E., Lanphear, B.P., Auinger, P., Hornung, R., Epstein, J.N., Braun, J., Kahn, R.S., Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics 124 (2009), e1054-e1063, 10.1542/peds 2009-0738.
59. Froemke, R.C., Plasticity of cortical excitatory-inhibitory balance. Annu. Rev. Neurosci. 38 (2015), 195-219, 10.1146/annurev-neuro-071714-034002.
60. Frye, R.E., Rossignol, D. a., Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr. Res. 69 (2011), 41-47, 10.1203/PDR.0b013e318212f16b.
61. Gafni, J., Wong, P.W., Pessah, I.N., Non-coplanar 2,2′,3,5′,6-pentachlorobiphenyl (PCB 95) amplifies ionotropic glutamate receptor signaling in embryonic cerebellar granule neurons by a mechanism involving ryanodine receptors. Toxicol. Sci. 77 (2004), 72-82, 10.1093/toxsci/kfh004.
62. Gentile, S., Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?. J. Affect. Disord. 182 (2015), 132-137, 10.1016/j.jad.2015.04.048.
63. Gilbert, M.E., Perinatal exposure to polychlorinated biphenyls alters excitatory synaptic transmission and short-term plasticity in the hippocampus of the adult rat. Neurotoxicology 24 (2003), 851-860, 10.1016/S0161-813X(03)00073-1.
64. Gilfillan, S.C., Lead poisoning and the fall of Rome. J. Occup. Med. 7 (1965), 53-60.
65. Goines, P.E., Ashwood, P., Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol. Teratol. 36 (2013), 67-81, 10.1016/j.ntt.2012.07.006.
66. Grandjean, P., Landrigan, P.J., Developmental neurotoxicity of industrial chemicals. Lancet 368 (2006), 2167-2178, 10.1016/S0140-6736(06)69665-7.
67. Grandjean, P., Landrigan, P.J., Neurobehavioural effects of developmental toxicity. Lancet Neurol. 13 (2014), 330-338, 10.1016/S1474-4422(13)70278-3.
68. Grandjean, P., Weihe, P., Debes, F., Choi, A.L., Budtz-Jørgensen, E., Neurotoxicity from prenatal and postnatal exposure to methylmercury. Neurotoxicol. Teratol. 43 (2014), 39-44, 10.1016/j.ntt.2014.03.004.
69. Harley, K.G., Gunier, R.B., Kogut, K., Johnson, C., Bradman, A., Calafat, A.M., Eskenazi, B., Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ. Res. 126 (2013), 43-50, 10.1016/j.envres.2013.06.004.
70. Haynes, D.R., Whitehouse, M.W., Vernon-Roberts, B., The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology 76:2 (1992), 251-257.
71. Hegazy, H.G., Ali, E.H. a., Elgoly, A.H.M., Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model. Cytokine 71 (2015), 173-180, 10.1016/j.cyto.2014.10.027.
72. Herbert, M.R., Russo, J.P., Yang, S., Roohi, J., Blaxill, M., Kahler, S.G., Cremer, L., Hatchwell, E., Autism and environmental genomics. Neurotoxicology 27 (2006), 671-684, 10.1016/j.neuro.2006.03.017.
73. Homberg, J.R., Schubert, D., Gaspar, P., New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 31 (2009), 60-65, 10.1016/j.tips.2009.11.003.
74. Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K., Patterson, P.H., Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. 109 (2012), 12776-12781, 10.1073/pnas.1202556109.
75. Imamura, Y., Nakane, Y., Ohta, Y., Kondo, H., Lifetime prevalence of schizophrenia among individuals prenatally exposed to atomic bomb radiation in Nagasaki City. Acta Psychiatr. Scand. 100 (1999), 344-349.
76. Ingram, J.L., Peckham, S.M., Tisdale, B., Rodier, P.M., Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22 (2000), 319-324, 10.1016/S0892-0362(99)00083-5.
77. Ito, T., Ando, H., Handa, H., Teratogenic effects of thalidomide: molecular mechanisms. Cell. Mol. Life Sci. 68 (2011), 1569-1579, 10.1007/s00018-010-0619-9.
78. Jacobson, J.L., Jacobson, S.W., Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N. Engl. J. Med. 335 (1996), 783-789, 10.1056/NEJM199609123351104.
79. Jacobson, J.L., Jacobson, S.W., Prenatal exposure to polychlorinated biphenyls and attention at school age. J. Pediatr. 143 (2003), 780-788, 10.1067/S0022-3476(03)00577-8.
80. Jacobson, C.F., Stump, D.G., Nemec, M.D., Holson, J.F., DeSesso, J.M., Appropriate exposure routes and doses in studies designed to assess developmental toxicity: a case study of inorganic arsenic. Int. J. Toxicol. 18 (1999), 361-368, 10.1080/109158199225279.
81. Jacobson, J.L., Muckle, G., Ayotte, P., Dewailly, É., Jacobson, S.W., Relation of prenatal methylmercury exposure from environmental sources to childhood IQ. Environ. Health Perspect. 123 (2015), 827-833, 10.1289/ehp.1408554.
82. Jaiswal, P., Mohanakumar, K.P., Rajamma, U., Serotonin mediated immunoregulation and neural functions: complicity in the aetiology of autism spectrum disorders. Neurosci. Biobehav. Rev. 55 (2015), 413-431, 10.1016/j.neubiorev.2015.05.013.
83. Janusonis, S., Serotonin dynamics in and around the central nervous system: is autism solvable without fundamental insights?. Int. J. Dev. Neurosci. 39 (2014), 9-15, 10.1016/j.ijdevneu.2014.05.009.
84. Johansson, C., Castoldi, A.F., Onishchenko, N., Manzo, L., Vahter, M., Ceccatelli, S., Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox. Res. 11 (2007), 241-260, 10.1007/BF03033570.
85. Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., Matsuda, T., Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol. 16 (2013), 91-103, 10.1017/S1461145711001714.
86. Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Yang, S. Il, Cheong, J.H., Shin, C.Y., Ko, K.H., The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett. 201 (2011), 137-142, 10.1016/j.toxlet.2010.12.018.
87. Kim, B.S., Kim, J.Y., Lee, J.G., Cho, Y., Huh, K.H., Kim, M.S., Kim, Y.S., Immune modulatory effect of thalidomide on T cells. Transplant Proc. 47:3 (2015), 787-790, 10.1016/j.transproceed.2014.12.038.
88. Kimura-Kuroda, J., Nagata, I., Kuroda, Y., Disrupting effects of hydroxy-polychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: a possible causal factor for developmental brain disorders?. Chemosphere 67 (2007), 412-420, 10.1016/j.chemosphere.2006.05.137.
89. Koger, S.M., Schettler, T., Weiss, B., Environmental toxicants and developmental disabilities: a challenge for psychologists. Am. Psychol. 60 (2005), 243-255, 10.1037/0003-066X.60.3.243.
90. Koibuchi, N., Iwasaki, T., Regulation of brain development by thyroid hormone and its modulation by environmental chemicals. Endocr. J. 53 (2006), 295-303, 10.1507/endocrj.KR-69.
91. Kozma, C., Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am. J. Med. Genet. 98 (2001), 168-175 doi: 10.1002/1096-8628(20010115)98:2<168:AID-AJMG1026>3.0. CO;2-O.
92. Kroon, T., Sierksma, M.C., Meredith, R.M., Investigating mechanisms underlying neurodevelopmental phenotypes of autistic and intellectual disability disorders: a perspective. Front. Syst. Neurosci. 7 (2013), 1-14, 10.3389/fnsys.2013.00075.
93. Lai, T.-J., Liu, X., Guo, Y.L., Guo, N.-W., Yu, M.-L., Hsu, C.-C., Rogan, W.J., A cohort study of behavioral problems and intelligence in children with high prenatal polychlorinated biphenyl exposure. Arch. Gen. Psychiatry 59 (2002), 1061-1066, 10.1001/archpsyc.59.11.1061.
94. Leblanc, J.J., Fagiolini, M., Autism: a critical period disorder?. Neural Plast., 2011, 1-17, 10.1155/2011/921680.
95. Loganovsky, K.N., Loganovskaja, T.K., Schizophrenia spectrum disorders in persons exposed to ionizing radiation as a result of the Chernobyl accident. Schizophr. Bull. 26 (2000), 751-773.
96. Loganovsky, K.N., Volovik, S.V., Manton, K.G., Bazyka, D.A., Flor-Henry, P., Whether ionizing radiation is a risk factor for schizophrenia spectrum disorders?. World J. Biol. Psychiatry 6 (2005), 212-230.
97. Lundstrom, R., Ahnsjo, S., Mental development following maternal rubella: a follow-up study of children born in 1951-1952. Acta Paediatr. 51 (1962), 153-159.
98. Man, K.K.C., Tong, H.H.Y., Wong, L.Y.L., Chan, E.W., Simonoff, E., Wong, I.C.K., Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies. Neurosci. Biobehav. Rev. 49 (2015), 82-89, 10.1016/j.neubiorev.2014.11.020.
99. Marco, E.M., MacRì, S., Laviola, G., Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models. Neurotox. Res. 19 (2011), 286-307, 10.1007/s12640-010-9205-z.
100. Marks, A.R., Harley, K., Bradman, A., Kogut, K., Barr, D.B., Johnson, C., Calderon, N., Eskenazi, B., Organophosphate pesticide exposure and attention in young Mexican-American children: the CHAMACOS study. Environ. Health Perspect. 118 (2010), 1768-1774, 10.1289/ehp.1002056.
101. Meijer, M., Dingemans, M.M.L., van den Berg, M., Westerink, R.H.S., Inhibition of voltage-gated calcium channels as common mode of action for (Mixtures of) distinct classes of insecticides. Toxicol. Sci. 141 (2014), 103-111, 10.1093/toxsci/kfu110.
102. Mendola, P., Selevan, S.G., Gutter, S., Rice, D.C., Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment. Retard. Dev. Disabil. Res. Rev. 8 (2002), 188-197, 10.1002/mrdd.10033.
103. Meredith, R.M., Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders. Neurosci. Biobehav. Rev. 50 (2015), 180-188, 10.1016/j.neubiorev.2014.12.001.
104. Meyer, U., Feldon, J., Dammann, O., Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr. Res. 69 (2011), 26-33, 10.1203/PDR.0b013e318212c196.
105. Miller, T.E., Golemboski, K.A., Ha, R.S., Bunn, T., Sanders, F.S., Dietert, R.R., Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol. Sci. 42 (1998), 129-135, 10.1006/toxs.1998.2424.
106. Miller, M., Strömland, K., Ventura, L.O., Johansson, M., Bandim, J.M., Gillberg, C., Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int. J. Dev. Neurosci. 23 (2005), 201-219, 10.1016/j.ijdevneu.2004.06.007.
107. Miodovnik, A., Environmental neurotoxicants and developing brain. Mt. Sinai J. Med. 78 (2011), 58-77, 10.1002/MSJ.
108. Mitchell, M.M., Woods, R., Chi, L.H., Schmidt, R.J., Pessah, I.N., Kostyniak, P.J., Lasalle, J.M., Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ. Mol. Mutagen 53 (2012), 589-598, 10.1002/em.21722.
109. Moore, S.J., Turnpenny, P., Quinn, a, Glover, S., Lloyd, D.J., Montgomery, T., Dean, J.C., A clinical study of 57 children with fetal anticonvulsant syndromes. J. Med. Genet. 37 (2000), 489-497, 10.1136/jmg.37.7.489.
110. Morreale De Escobar, G., Obregon, M.J., Escobar Del Rey, F., Role of thyroid hormone during early brain development. Eur. J. Endocrinol. 151 (2004), U25-U37, 10.1530/eje.0.151U025.
111. Myers, G.J., Davidson, P.W., Does methylmercury have a role in causing developmental disabilities in children?. Environ. Health Perspect. 108 (2000), 413-420, 10.1289/ehp.00108s3413.
112. Myers, G.J., Davidson, P.W., Cox, C., Shamlaye, C., Palumbo, D., Cernichiari, E., Sloane-Reeves, J., Wilding, G., Kost, J., Huang, L., Clarkson, T., Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 361 (2003), 1686-1692.
113. Narita, N., Kato, M., Tazoe, M., Miyazaki, K., Narita, M., Okado, N., Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52 (2002), 576-579, 10.1203/00006450-200210000-00018.
114. National Research Council, Pesticides in the Diets of Infants and Children. 1993, National Academy Press, Washington DC.
115. Nevin, R., Trends in preschool lead exposure, mental retardation, and scholastic achievement: association or causation?. Environ. Res. 109 (2009), 301-310.
116. Newland, M.C., Reed, M.N., Rasmussen, E., A hypothesis about how early developmental methylmercury exposure disrupts behavior in adulthood. Behav. Processes 114 (2015), 41-51, 10.1016/j.beproc.2015.03.007.
117. Nicolini, C., Ahn, Y., Michalski, B., Rho, J.M., Fahnestock, M., Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol. Commun. 3 (2015), 1-13, 10.1186/s40478-015-0184-4.
118. Nyagu, A.I., Loganovsky, K.N., Loganovskaja, T.K., Psychophysiologic aftereffects of prenatal irradiation. Int. J. Psychophysiol. 30 (1998), 303-311, 10.1016/S0167-8760(98)00022-1.
119. Oberlander, T.F., Gingrich, J.A., Ansorge, M.S., Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther. 86 (2009), 672-677, 10.1038/clpt.2009.201.
120. Ookubo, M., Sadamatsu, M., Yoshimura, A., Suzuki, S., Kato, N., Kojima, H., Yamada, N., Kanai, H., Aberrant monoaminergic system in thyroid hormone receptor- deficient mice as a model of attention-deficit/hyperactivity disorder. Int. J. Neuropsychopharmacol. 1 (2015), 1-9, 10.1093/ijnp/pyv004.
121. Opler, M.G.A., Brown, A.S., Graziano, J., Desai, M., Zheng, W., Schaefer, C., Factor-Litvak, P., Susser, E.S., Prenatal lead exposure, δ-aminolevulinic acid, and schizophrenia. Environ. Health Perspect. 112 (2004), 548-552, 10.1289/ehp.6777.
122. Ornoy, A., Weinstein-Fudim, L., Ergaz, Z., Prenatal factors associated with autism spectrum disorder (ASD). Reprod. Toxicol., 2015, 155-169, 10.1016/j.reprotox.2015.05.007.
123. Otake, M., Schull, W., Lee, S., Threshold for radiation-related severe mental retardation in prenatally exposed A-bomb survivors: a re-analysis. Int. J. Radiat. Biol. 70 (1996), 755-763.
124. Oyabu, A., Narita, M., Tashiro, Y., The effects of prenatal exposure to valproic acid on the initial development of serotonergic neurons. Int. J. Dev. Neurosci. 31:3 (2013), 202-208, 10.1016/j.ijdevneu.2013.01.006.
125. Palmer, A. a., Printz, D.J., Butler, P.D., Dulawa, S.C., Printz, M.P., Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Res. 996 (2004), 193-201, 10.1016/j.brainres.2003.09.077.
126. Patterson, P.H., Maternal infection and immune involvement in autism. Trends Mol. Med. 17 (2011), 389-394, 10.1016/j.molmed.2011.03.001.
127. Plusquellec, P., Muckle, G., Dewailly, E., Ayotte, P., Bégin, G., Desrosiers, C., Després, C., Saint-Amour, D., Poitras, K., The relation of environmental contaminants exposure to behavioral indicators in Inuit preschoolers in Arctic Quebec. Neurotoxicology 31 (2010), 17-25, 10.1016/j.neuro.2009.10.008.
128. Porterfield, S.P., Thyroidal dysfunction and environmental chemicals-potential impact on brain development. Environ. Health Perspect. 108 (2000), 433-438, 10.1289/ehp.00108s3433.
129. Prabakaran, S., Swatton, J.E., Ryan, M.M., Huffaker, S.J., Huang, J.T.-J., Griffin, J.L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K.S., Karp, N.A., Hester, S., Tkachev, D., Mimmack, M.L., Yolken, R.H., Webster, M.J., Torrey, E.F., Bahn, S., Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9 (2004), 684-697, 10.1038/sj.mp.4001532.
130. Prakash, C., Soni, M., Kumar, V., Biochemical and molecular alterations following arsenic-induced oxidative stress and mitochondrial dysfunction in rat brain. Biol. Trace Elem. Res. 167 (2015), 121-129, 10.1007/s12011-015-0284-9.
131. Quaak, I., Brouns, M.R., van de Bor, M., The dynamics of Autism Spectrum Disorders: how neurotoxic compounds and neurotransmitters interact. Int. J. Environ. Res. Public Health 10 (2013), 3384-3408, 10.3390/ijerph10083384.
132. Rauh, V., Garfinkel, R., Perera, F., Andrews, H., Hoepner, L., Barr, D., Whitehead, R., Tang, D., Whyatt, R., Impact of prenatal chlorpyrifos exposure on neurodevelopment en the first 3 years of life among inner-city children. Pediatrics 118 (2006), e1845-e1859, 10.1016/j.biotechadv.2011.08.021.
133. Reyes, J.W., Environmental policy as social policy? The impact of childhood lead exposure on crime. BE J. Econ. Anal. Policy, 7, 2007, 10.2202/1935-1682.1796.
134. Ribas-Fitó, N., Sala, M., Kogevinas, M., Sunyer, J., Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J. Epidemiol. Community Health 55 (2001), 537-546, 10.1136/jech.55.8.537.
135. Rice, D.C., Barone, S., Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (2000), 511-533, 10.1289/ehp.00108s3511.
136. Rice, D.C., Hayward, S., Effects of postnatal exposure of monkeys to a PCB mixture on concurrent random interval-random interval and progressive ratio performance. Neurotoxicol. Teratol. 21 (1999), 47-58, 10.1016/S0892-0362(98)00032-4.
137. Rice, D.C., Effect of postnatal exposure to a PCB mixture in monkeys on multiple fixed interval-fixed ratio performance. Neurotoxicol. Teratol. 19 (1997), 429-434, 10.1016/S0892-0362(97)87364-3.
138. Rice, D.C., Behavioral impairment produced by low-level postnatal PCB exposure in monkeys. Environ. Res. 80 (1999), S113-S121 http://dx.doi.org/10.1006/enrs.1998.3917.
139. Rice, D.C., Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ. Health Perspect. 108 (2000), 405-408, 10.1289/ehp.00108s3405.
140. Roberts, E.M., English, P.B., Bayesian modeling of time-dependent vulnerability to environmental hazards: an example using autism and pesticide data. Stat. Med. 32 (2013), 2308-2319.
141. Roberts, E.M., English, P.B., Grether, J., Windham, G.C., Somberg, L., Wolff, C., Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ. Health Perspect. 115 (2007), 1482-1489, 10.1289/ehp.10168.
142. Roberts, A.L., Lyall, K., Hart, J.E., Laden, F., Just, A.C., Bobb, J.F., Koenen, K.C., Ascherio, A., Weisskopf, M.G., Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses’ Health Study II participants. Environ. Health Perspect. 121 (2013), 978-984, 10.1289/ehp.1206187.
143. Rodier, P.M., Ingram, J.L., Tisdale, B., Nelson, S., Romano, J., Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370:2 (1996), 247-261 doi:10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2.
144. Rodier, P.M., Ingram, J.L., Tisdale, B., Croog, V.J., Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 11 (1997), 417-422, 10.1016/S0890-6238(97)80001-U.
145. Rodier, P.M., Converging evidence for brain stem injury in autism. Dev. Psychopathol. 14 (2002), 537-557, 10.1017/S0954579402003085.
146. Rodríguez-Barranco, M., Gil, F., Hernández, A.F., Alguacil, J., Lorca, A., Mendoza, R., Gómez, I., Molina-Villalba, I., González-Alzaga, B., Aguilar-Garduño, C., Rohlman, D.S., Lacasaña, M., Postnatal arsenic exposure and attention impairment in school children. Cortex, 2015, 1-13, 10.1016/j.cortex.2014.12.018.
147. Rogers, J. a., Metz, L., Yong, V.W., Review: endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol. Immunol. 53 (2013), 421-430, 10.1016/j.molimm.2012.09.013.
148. Romano, M.E., Webster, G.M., Vuong, A.M., Zoeller, R.T., Chen, A., Hoofnagle, A.N., Calafat, A.M., Karagas, M.R., Yolton, K., Lanphear, B.P., Braun, J.M., Gestational urinary bisphenol A and maternal and newborn thyroid hormone concentrations: the HOME study. Environ. Res. 138 (2015), 453-460, 10.1016/j.envres.2015.03.003.
149. Rooney, A.A., Matulka, R.A., Leubke, R.W., Developmental atrazine exposure suppresses immune function in male, but not female sprague-dawley rats. Toxicol. Sci. 76 (2003), 366-375, 10.1093/toxsci/kfg250.
150. Rossignol, D.A., Frye, R.E., A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol. Psychiatry 17 (2012), 389-401, 10.1038/mp.2011.165.
151. Rossignol, D.A., Genuis, S.J., Frye, R.E., Environmental toxicants and autism spectrum disorders: a systematic review. Transl. Psychiatry 4 (2014), 1-23, 10.1038/tp.2014.4.
152. Roullet, F.I., Lai, J.K.Y., Foster, J.A., In utero exposure to valproic acid and autism - A current review of clinical and animal studies. Neurotoxicol. Teratol. 36 (2013), 47-56, 10.1016/j.ntt.2013.01.004.
153. Rubenstein, J., Merzenich, M., Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2 (2003), 255-267, 10.1046/j.1601-183X.2003.00037.x.
154. Rumajogee, P., Vergé, D., Hanoun, N., Brisorgueil, M.J., Hen, R., Lesch, K.P., Hamon, M., Miquel, M.C., Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP. Eur. J. Neurosci. 19 (2004), 937-944, 10.1111/j.0953-816X.2004.03194.x.
155. Sagiv, S.K., Thurston, S.W., Bellinger, D.C., Tolbert, P.E., Altshul, L.M., Korrick, S.A., Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am. J. Epidemiol. 171 (2010), 593-601, 10.1093/aje/kwp427.
156. Sagiv, S.K., Thurston, S.W., Bellinger, D.C., Amarasiriwardena, C., Korrick, S.A., Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch. Pediatr. Adolesc. Med. 166 (2012), 1123-1131, 10.1001/archpediatrics.2012.1286.
157. Schneider, T., Przewłocki, R., Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005), 80-89, 10.1038/sj.npp.1300518.
158. Selevan, S.G., Kimmel, C. a., Mendola, P., Identifying critical windows of exposure for children's health. Environ. Health Perspect. 108 (2000), 451-455, 10.1289/ehp.00108s3451.
159. Sharma, A., Couture, J., A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann. Pharmacother. 48 (2014), 209-225, 10.1177/1060028013510699.
160. Shelton, J.F., Hertz-Picciotto, I., Pessah, I.N., Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ. Health Perspect. 120 (2012), 944-951, 10.1289/ehp.1104553.
161. Shelton, J.F., Geraghty, E.M., Tancredi, D.J., Delwiche, L.D., Schmidt, R.J., Ritz, B., Hansen, R.L., Hertz-Picciotto, I., Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ. Health Perspect. 122 (2014), 1103-1109.
162. 10.1289/ehp.1307044.
163. Shenker, B.J., Guo, T.L., O.I, Shapiro, I.M., Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol. Appl. Pharmacol. 157:1 (1999), 23-35.
164. Shi, L., Fatemi, S.H., Sidwell, R.W., Patterson, P.H., Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23 (2003), 297-302 (23/1/297 [pii]).
165. Silva, E., Rajapakse, N., Kortenkamp, A., Something from nothing - eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol. 36 (2002), 1751-1756, 10.1021/es0101227.
166. Stewart, P., Fitzgerald, S., Reihman, J., Gump, B., Lonky, E., Darvill, T., Pagano, J., Hauser, P., Prenatal PCB exposure, the corpus callosum, and response inhibition. Environ. Health Perspect. 111 (2003), 1670-1677, 10.1289/ehp.6173.
167. Strömland, K., Nordin, V., Miller, M., Akerström, B., Gillberg, C., Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 36 (1994), 351-356.
168. Susser, E., Neugebauer, R., Hoek, H.W., Brown, A.S., Lin, S., Labovitz, D., Gorman, J.M., Schizophrenia after prenatal famine: further evidence. Arch. Gen. Psychiatry 53 (1996), 25-31.
169. Symeonides, C., Ponsonby, A.-L., Vuillermin, P., Anderson, V., Sly, P., Environmental chemical contributions to ADHD and the externalising disorders of childhood - a review of epidemiological evidence. J. Environ. Immunol. Toxicol. 1 (2014), 92-104, 10.7178/jeit.21.
170. Takesian, A.E., Hensch, T.K., Balancing plasticity/stability across brain development. Progress in Brain Research, 1 st ed., 2013, Elsevier B.V., 10.1016/B978-0-444-63327-9.00001-1.
171. Tilson, H.A., Jacobson, J.L., Rogan, W.J., Polychlorinated biphenyls and the developing nervous system: cross-species comparisons. Neurotoxicol. Teratol. 12 (1990), 239-248, 10.1016/0892-0362(90)90095-T.
172. Tolins, M., Ruchirawat, M., Landrigan, P., The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure. Ann. Glob. Heal. 80 (2014), 303-314, 10.1016/j.aogh.2014.09.005.
173. Tsai, S.Y., Chou, H.Y., The, H.W., Chen, C.M., Chen, C.J., The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 24 (2003), 747-753, 10.1016/S0161-813X(03)00029-9.
174. Tyler, C.R., Allan, A.M., The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr. Environ. Heal. Rep. 1 (2014), 132-147, 10.1007/s40572-014-0012-1.
175. Vandenberg, L.N., Chahoud, I., Heindel, J.J., Padmanabhan, V., Paumgartten, F.J.R., Schoenfelder, G., Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 118 (2010), 1055-1070, 10.1289/ehp.0901716.
176. Veiga-Lopez, A., Pennathur, S., Kannan, K., Patisaul, H.B., Dolinoy, D.C., Zeng, L., Padmanabhan, V., Impact of gestational bisphenol a on oxidative stress and free fatty acids: human association and interspecies animal testing studies. Endocrinology 156 (2015), 911-922, 10.1210/en.2014-1863.
177. Verlaet, A.a.J., Noriega, D.B., Hermans, N., Savelkoul, H.F.J., Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur. Child Adolesc. Psychiatry 23 (2014), 519-529, 10.1007/s00787-014-0522-2.
178. Viberg, H., Fredriksson, A., Buratovic, S., Eriksson, P., Dose-dependent behavioral disturbances after a single neonatal Bisphenol A dose. Toxicology 290 (2011), 187-194, 10.1016/j.tox.2011.09.006.
179. Vos, T., Barber, R.M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., Duan, L., Erskine, H., Feigin, V.L., Ferrari, A.J., Fitzmaurice, C., Fleming, T., Graetz, N., Guinovart, C., Haagsma, J., Hansen, G.M., Hanson, S.W., Heuton, K.R., Higashi, H., Kassebaum, N., Kyu, H., Laurie, E., Liang, X., Lofgren, K., Lozano, R., MacIntyre, M.F., Moradi-Lakeh, M., Naghavi, M., Nguyen, G., Odell, S., Ortblad, K., Roberts, D.A., Roth, G. a., Sandar, L., Serina, P.T., Stanaway, J.D., Steiner, C., Thomas, B., Vollset, S.E., Whiteford, H., Wolock, T.M., Ye, P., Zhou, M., Vila, M. a., Aasvang, G.M., Abbafati, C., Ozgoren, A.A., Abd-Allah, F., Aziz, M.I.A., Abera, S.F., Aboyans, V., Abraham, J.P., Abraham, B., Abubakar, I., Abu-Raddad, L.J., Abu-Rmeileh, N.M.E., Aburto, T.C., Achoki, T., Ackerman, I.N., Adelekan, A., Ademi, Z., Adou, A.K., Adsuar, J.C., Arnlov, J., Agardh, E.E., Al Khabouri, M.J., Alam, S.S., Alasfoor, D., Albittar, M.I., Alegretti, M. a., Aleman, A.V., Alemu, Z. a., Alfonso-Cristancho, R., Alhabib, S., Ali, R., Alla, F., Allebeck, P., Allen, P.J., AlMazroa, M.A., Alsharif, U., Alvarez, E., Alvis-Guzman, N., Ameli, O., Amini, H., Ammar, W., Anderson, B.O., Anderson, H.R., Antonio, C.A.T., Anwari, P., Apfel, H., Arsenijevic, V.S.A., Artaman, A., Asghar, R.J., Assadi, R., Atkins, L.S., Atkinson, C., Badawi, A., Bahit, M.C., Bakfalouni, T., Balakrishnan, K., Balalla, S., Banerjee, A., Barker-Collo, S.L., Barquera, S., Barregard, L., Barrero, L.H., Basu, S., Basu, A., Baxter, A., Beardsley, J., Bedi, N., Beghi, E., Bekele, T., Bell, M.L., Benjet, C., Bennett, D. a., Bensenor, I.M., Benzian, H., Bernabe, E., Beyene, T.J., Bhala, N., Bhalla, A., Bhutta, Z., Bienhoff, K., Bikbov, B., Abdulhak, A., Bin, Blore, J.D., Blyth, F.M., Bohensky, M. a., Basara, B.B., Borges, G., Bornstein, N.M., Bose, D., Boufous, S., Bourne, R.R., Boyers, L.N., Brainin, M., Brauer, M., Brayne, C.E.G., Brazinova, A., Breitborde, N.J.K., Brenner, H., Briggs, A.D.M., Brooks, P.M., Brown, J., Brugha, T.S., Buchbinder, R., Buckle, G.C., Bukhman, G., Bulloch, A.G., Burch, M., Burnett, R., Cardenas, R., Cabral, N.L., Campos-Nonato, I.R., Campuzano, J.C., Carapetis, J.R., Carpenter, D.O., Caso, V., Castaneda-Orjuela, C. a., Catala-Lopez, F., Chadha, V.K., Chang, J.C., Chen, H., Chen, W., Chiang, P.P., Chimed-Ochir, O., Chowdhury, R., Christensen, H., Christophi, C. a., Chugh, S.S., Cirillo, M., Coggeshall, M., Cohen, A., Colistro, V., Colquhoun, S.M., Contreras, A.G., Cooper, L.T., Cooper, C., Cooperrider, K., Coresh, J., Cortinovis, M., Criqui, M.H., Crump, J. a., Cuevas-Nasu, L., Dandona, R., Dandona, L., Dansereau, E., Dantes, H.G., Dargan, P.I., Davey, G., Davitoiu, D.V., Dayama, A., De La Cruz-Gongora, V., De La Vega, S.F., De Leo, D., Del Pozo-Cruz, B., Dellavalle, R.P., Deribe, K., Derrett, S., Des Jarlais, D.C., Dessalegn, M., DeVeber, G. a., Dharmaratne, S.D., Diaz-Torne, C., Ding, E.L., Dokova, K., Dorsey, E.R., Driscoll, T.R., Duber, H., Durrani, A.M., Edmond, K.M., Ellenbogen, R.G., Endres, M., Ermakov, S.P., Eshrati, B., Esteghamati, A., Estep, K., Fahimi, S., Farzadfar, F., Fay, D.F.J., Felson, D.T., Fereshtehnejad, S.M., Fernandes, J.G., Ferri, C.P., Flaxman, A., Foigt, N., Foreman, K.J., Fowkes, F.G.R., Franklin, R.C., Furst, T., Futran, N.D., Gabbe, B.J., Gankpe, F.G., Garcia-Guerra, F. a., Geleijnse, J.M., Gessner, B.D., Gibney, K.B., Gillum, R.F., Ginawi, I. a., Giroud, M., Giussani, G., Goenka, S., Goginashvili, K., Gona, P., De Cosio, T.G., Gosselin, R. a., Gotay, C.C., Goto, A., Gouda, H.N., Guerrant, R.L., Gugnani, H.C., Gunnell, D., Gupta, R., Gupta, R., Gutierrez, R. a., Hafezi-Nejad, N., Hagan, H., Halasa, Y., Hamadeh, R.R., Hamavid, H., Hammami, M., Hankey, G.J., Hao, Y., Harb, H.L., Haro, J.M., Havmoeller, R., Hay, R.J., Hay, S., Hedayati, M.T., Pi, I.B.H., Heydarpour, P., Hijar, M., Hoek, H.W., Hoffman, H.J., Hornberger, J.C., Hosgood, H.D., Hossain, M., Hotez, P.J., Hoy, D.G., Hsairi, M., Hu, H., Hu, G., Huang, J.J., Huang, C., Huiart, L., Husseini, A., Iannarone, M., Iburg, K.M., Innos, K., Inoue, M., Jacobsen, K.H., Jassal, S.K., Jeemon, P., Jensen, P.N., Jha, V., Jiang, G., Jiang, Y., Jonas, J.B., Joseph, J., Juel, K., Kan, H., Karch, A., Karimkhani, C., Karthikeyan, G., Katz, R., Kaul, A., Kawakami, N., Kazi, D.S., Kemp, A.H., Kengne, A.P., Khader, Y.S., Khalifa, S.E. a H., Khan, E. a., Khan, G., Khang, Y.H., Khonelidze, I., Kieling, C., Kim, D., Kim, S., Kimokoti, R.W., Kinfu, Y., Kinge, J.M., Kissela, B.M., Kivipelto, M., Knibbs, L., Knudsen, A.K., Kokubo, Y., Kosen, S., Kramer, A., Kravchenko, M., Krishnamurthi, R.V., Krishnaswami, S., Defo, B.K., Bicer, B.K., Kuipers, E.J., Kulkarni, V.S., Kumar, K., Kumar, G.A., Kwan, G.F., Lai, T., Lalloo, R., Lam, H., Lan, Q., Lansingh, V.C., Larson, H., Larsson, A., Lawrynowicz, A.E.B., Leasher, J.L., Lee, J.T., Leigh, J., Leung, R., Levi, M., Li, B., Li, Y., Li, Y., Liang, J., Lim, S., Lin, H.H., Lind, M., Lindsay, M.P., Lipshultz, S.E., Liu, S., Lloyd, B.K., Ohno, S.L., Logroscino, G., Looker, K.J., Lopez, A.D., Lopez-Olmedo, N., Lortet-Tieulent, J., Lotufo, P. a., Low, N., Lucas, R.M., Lunevicius, R., Lyons, R. a., Ma, J., Ma, S., MacKay, M.T., Majdan, M., Malekzadeh, R., Mapoma, C.C., Marcenes, W., March, L.M., Margono, C., Marks, G.B., Marzan, M.B., Masci, J.R., Mason-Jones, A.J., Matzopoulos, R.G., Mayosi, B.M., Mazorodze, T.T., McGill, N.W., McGrath, J.J., McKee, M., McLain, A., McMahon, B.J., Meaney, P. a., Mehndiratta, M.M., Mejia-Rodriguez, F., Mekonnen, W., Melaku, Y. a., Meltzer, M., Memish, Z. a., Mensah, G., Meretoja, A., Mhimbira, F. a., Micha, R., Miller, T.R., Mills, E.J., Mitchell, P.B., Mock, C.N., Moffitt, T.E., Ibrahim, N.M., Mohammad, K. a., Mokdad, A.H., Mola, G.L., Monasta, L., Montico, M., Montine, T.J., Moore, A.R., Moran, A.E., Morawska, L., Mori, R., Moschandreas, J., Moturi, W.N., Moyer, M., Mozaffarian, D., Mueller, U.O., Mukaigawara, M., Murdoch, M.E., Murray, J., Murthy, K.S., Naghavi, P., Nahas, Z., Naheed, A., Naidoo, K.S., Naldi, L., Nand, D., Nangia, V., Narayan, K.M.V., Nash, D., Nejjari, C., Neupane, S.P., Newman, L.M., Newton, C.R., Ng, M., Ngalesoni, F.N., Nhung, N.T., Nisar, M.I., Nolte, S., Norheim, O.F., Norman, R.E., Norrving, B., Nyakarahuka, L., Oh, I.H., Ohkubo, T., Omer, S.B., Opio, J.N., Ortiz, A., Pandian, J.D., Panelo, C.I., a, Papachristou, C., Park, E.K., Parry, C.D., Caicedo, A.J.P., Patten, S.B., Paul, V.K., Pavlin, B.I., Pearce, N., Pedraza, L.S., Pellegrini, C. a., Pereira, D.M., Perez-Ruiz, F.P., Perico, N., Pervaiz, A., Pesudovs, K., Peterson, C.B., Petzold, M., Phillips, M.R., Phillips, D., Phillips, B., Piel, F.B., Plass, D., Poenaru, D., Polanczyk, G.V., Polinder, S., Pope, C. a., Popova, S., Poulton, R.G., Pourmalek, F., Prabhakaran, D., Prasad, N.M., Qato, D., Quistberg, D. a., Rafay, A., Rahimi, K., Rahimi-Movaghar, V., Rahman, S.U., Raju, M., Rakovac, I., Rana, S.M., Razavi, H., Refaat, A., Rehm, J., Remuzzi, G., Resnikoff, S., Ribeiro, A.L., Riccio, P.M., Richardson, L., Richardus, J.H., Riederer, A.M., Robinson, M., Roca, A., Rodriguez, A., Rojas-Rueda, D., Ronfani, L., Rothenbacher, D., Roy, N., Ruhago, G.M., Sabin, N., Sacco, R.L., Ksoreide, K., Saha, S., Sahathevan, R., Sahraian, M.A., Sampson, U., Sanabria, J.R., Sanchez-Riera, L., Santos, I.S., Satpathy, M., Saunders, J.E., Sawhney, M., Saylan, M.I., Scarborough, P., Schoettker, B., Schneider, I.J.C., Schwebel, D.C., Scott, J.G., Seedat, S., Sepanlou, S.G., Serdar, B., Servan-Mori, E.E., Shackelford, K., Shaheen, A., Shahraz, S., Levy, T.S., Shangguan, S., She, J., Sheikhbahaei, S., Shepard, D.S., Shi, P., Shibuya, K., Shinohara, Y., Shiri, R., Shishani, K., Shiue, I., Shrime, M.G., Sigfusdottir, I.D., Silberberg, D.H., Simard, E.P., Sindi, S., Singh, J. a., Singh, L., Skirbekk, V., Sliwa, K., Soljak, M., Soneji, S., Soshnikov, S.S., Speyer, P., Sposato, L. a., Sreeramareddy, C.T., Stoeckl, H., Stathopoulou, V.K., Steckling, N., Stein, M.B., Stein, D.J., Steiner, T.J., Stewart, A., Stork, E., Stovner, L.J., Stroumpoulis, K., Sturua, L., Sunguya, B.F., Swaroop, M., Sykes, B.L., Tabb, K.M., Takahashi, K., Tan, F., Tandon, N., Tanne, D., Tanner, M., Tavakkoli, M., Taylor, H.R., Te Ao, B.J., Temesgen, A.M., Have, M., Ten, Tenkorang, E.Y., Terkawi, A.S., Theadom, A.M., Thomas, E., Thorne-Lyman, A.L., Thrift, A.G., Tleyjeh, I.M., Tonelli, M., Topouzis, F., Towbin, J. a., Toyoshima, H., Traebert, J., Tran, B.X., Trasande, L., Trillini, M., Truelsen, T., Trujillo, U., Tsilimbaris, M., Tuzcu, E.M., Ukwaja, K.N., Undurraga, E. a., Uzun, S.B., Van Brakel, W.H., Van De Vijver, S., Dingenen, R., Van, Van Gool, C.H., Varakin, Y.Y., Vasankari, T.J., Vavilala, M.S., Veerman, L.J., Velasquez-Melendez, G., Venketasubramanian, N., Vijayakumar, L., Villalpando, S., Violante, F.S., Vlassov, V.V., Waller, S., Wallin, M.T., Wan, X., Wang, L., Wang, J., Wang, Y., Warouw, T.S., Weichenthal, S., Weiderpass, E., Weintraub, R.G., Werdecker, A., Wessells, K.R., Westerman, R., Wilkinson, J.D., Williams, H.C., Williams, T.N., Woldeyohannes, S.M., Wolfe, C.D., a, Wong, J.Q., Wong, H., Woolf, A.D., Wright, J.L., Wurtz, B., Xu, G., Yang, G., Yano, Y., Yenesew, M. a., Yentur, G.K., Yip, P., Yonemoto, N., Yoon, S.J., Younis, M., Yu, C., Kim, K.Y., Zaki, M.E.S., Zhang, Y., Zhao, Z., Zhao, Y., Zhu, J., Zonies, D., Zunt, J.R., Salomon, J. a., Murray, C.J.L., 2015. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743-800. 10.1016/S0140-6736(15)60692-4.
180. Walter, H., Consolaro, F., Gramatica, P., Scholze, M., Altenburger, R., Mixture toxicity of priority pollutants at no observed effect concentrations (NOECs). Ecotoxicology 11 (2002), 299-310, 10.1023/A.1020592802989.
181. Wasserman, G.A., Staghezza-Jaramillo, B., Shrout, P., Popovac, D., Graziano, J., The effect of lead exposure on behavior problems in preschool children. Am. J. Public Health 88 (1998), 481-486, 10.2105/AJPH.88.3.481.
182. Wasserman, G., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., van Geen, A., Slavkovich, V., Lolacono, N., Cheng, Z., Hussain, I., Momotaj, H., Graziano, J., Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 112 (2004), 1329-1333, 10.1289/ehp.6964.
183. Wei, H., Alberts, I., Li, X., The apoptotic perspective of autism. Int. J. Dev. Neurosci. 36 (2014), 13-18, 10.1016/j.ijdevneu.2014.04.004.
184. Weiss, B., Amler, S., Amler, R.W., Pesticides. Pediatrics 113 (2004), 1030-1036.
185. Whitaker-Azmitia, P.M., Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int. J. Dev. Neurosci. 23 (2005), 75-83, 10.1016/j.ijdevneu.2004.07.022.
186. Williams, J.H.G., Ross, L., Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review. Eur. Child Adolesc. Psychiatry 16 (2007), 243-253, 10.1007/s00787-006-0596-6.
187. Winneke, G., Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls. J. Neurol. Sci. 308 (2011), 9-15, 10.1016/j.jns.2011.05.020.
188. Winter, C., Reutiman, T.J., Folsom, T.D., Sohr, R., Wolf, R.J., Juckel, G., Fatemi, S.H., Dopamine and serotonin levels following prenatal viral infection in mouse-implications for psychiatric disorders such as schizophrenia and autism. Eur. Neuropsychopharmacol. 18 (2008), 712-716, 10.1016/j.euroneuro.2008.06.001.
189. Wise, A., Parham, F., Axelrad, D. a., Guyton, K.Z., Portier, C., Zeise, L., Zoeller, R.T., Woodruff, T.J., Upstream adverse effects in risk assessment: a model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans. Environ. Res. 117 (2012), 90-99, 10.1016/j.envres.2012.05.013.
190. Workman, A.D., Charvet, C.J., Clancy, B., Darlington, R.B., Finlay, B.L., Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci. 33 (2013), 7368-7383, 10.1523/JNEUROSCI (5746-12.2013).
191. World Health Organization, Ionizing Radiation, Health Effects and Protective Measures (fact Sheet 371) [WWW Document]. 2016, World Health Organization (URL http://www.who.int/mediacentre/factsheets/fs371/en/).
192. Xu, M.Q., Sun, W.S., Liu, B.X., Feng, G.Y., Yu, L., Yang, L., He, G., Sham, P., Susser, E., St. Clair, D., He, L., Prenatal malnutrition and adult Schizophrenia: further evidence from the 1959-1961 Chinese famine. Schizophr. Bull. 35 (2009), 568-576, 10.1093/schbul/sbn168.
193. Yamashita, N., Doi, M., Nishio, M., Hojo, H., Tanaka, M., Recent observations of Kyoto children poisoned by arsenic tainted “Morinaga Dry Milk”. Nippon Eiseigaku Zasshi 27:4 (1972), 364-399.
194. Yan, Z., Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications. Mol. Neurobiol. 26 (2002), 203-216, 10.1385/MN:26:2-3:203.
195. Zoeller, T.R., Dowling, A.L.S., Herzig, C.T., a Iannacone, E., a Gauger, K.J., Bansal, R., Thyroid hormone, brain development, and the environment. Environ. Health Perspect. 110 (2002), 355-361.
196. Zuckerman, L., Rehavi, M., Nachman, R., Weiner, I., Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003), 1778-1789, 10.1038/sj.npp.1300248.